Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 1 5Phase NA 3Phase 3 3Phase 1/2 2

Status

Completed 13Active not recruiting 8Unknown 3Terminated 3Withdrawn 1Recruiting 1

Sponsor Class

OTHER 1NIH 1NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 2Genitourinary 1CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Prostatic Neoplasms 1Lung Neoplasms 1Brain Neoplasms 1

Interventions

Cisplatin 62Carboplatin 52Paclitaxel 48Radiotherapy 47Docetaxel 41Gemcitabine 38Cyclophosphamide 36Rituximab 33Capecitabine 28Fluorouracil 27Dexamethasone 27Doxorubicin 26Prednisone 21Bevacizumab 20Pemetrexed 19Oxaliplatin 18Leucovorin 18pembrolizumab 17Vincristine 17Etoposide 17Cytarabine 15Drug Therapy 14Irinotecan 13Imatinib Mesylate 13Filgrastim 13Zoledronic Acid 12Radiosurgery 12Erlotinib Hydrochloride 12Trastuzumab 11Goserelin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Terminated × Radiotherapy, Conformal × Clear all
NCT02768558 2021-06-02

Cisplatin and Etoposide Plus Radiation Followed By Nivolumab/Placebo For Locally Advanced NSCLC

RTOG Foundation, Inc.

Phase 3 Terminated
20 enrolled 14 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00096265 2018-03-09

Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 3 Terminated
126 enrolled 14 charts
CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT00949962 2014-07-04

Post-operative or Early Salvage XRT and ADT for High Risk PCa

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Terminated
87 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡